Back to top

VivoSim enters China with first commercial sales of NAMkind testing services

VivoSim (VIVS) announced its first commercial sales in China, opening a new market for its NAMkind testing services. VivoSim delivers both toxicolo...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: